Cargando…

Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine

Breast cancer is one of the most commonly diagnosed and death-related cancers in women worldwide. Mammography is routinely used for screening and invasive examinations such as painful tissue biopsies were recommended for patients with abnormal screening outcomes. However, a considerable proportion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Cheng, Li, Xiaofen, Ye, Minfeng, Xu, Fei, Yu, Jiekai, Xie, Cong, Cao, Xiaoji, Guo, Mengzhe, Yuan, Ying, Zheng, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581095/ https://www.ncbi.nlm.nih.gov/pubmed/28881796 http://dx.doi.org/10.18632/oncotarget.17831

Ejemplares similares

Potential application of the oxidative nucleic acid damage biomarkers in detection of diseases
por: Guo, Cheng, et al.
Publicado: (2017)

Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2′-deoxyguanosine by UPLC-MS/MS Analysis
por: Guo, Cheng, et al.
Publicado: (2016)

Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma
por: Zhao, Wei, et al.
Publicado: (2015)

Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach
por: Yu, Jiekai, et al.
Publicado: (2017)

Alterations in expressed prostate secretion-urine PSA N-glycosylation discriminate prostate cancer from benign prostate hyperplasia
por: Jia, Gaozhen, et al.
Publicado: (2017)

High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers
por: Yu, Jiekai, et al.
Publicado: (2016)

Diagnostic value of multiple b-value diffusion-weighted imaging in discriminating the malignant from benign breast lesions
por: Lin, Chu-Xin, et al.
Publicado: (2023)

A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions
por: Liang, Lei, et al.
Publicado: (2021)

Value of shear wave elastography in discriminating malignant and benign breast lesions: A meta-analysis
por: Xue, Yan, et al.
Publicado: (2017)

Discrimination of Malignant and Benign Breast Lesions Using Quantitative Multiparametric MRI: A Preliminary Study
por: Li, Kurt, et al.
Publicado: (2020)

Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions
por: Chen, Xiaoli, et al.
Publicado: (2016)

Targeting the NAD(+) salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level
por: Ye, Chenyang, et al.
Publicado: (2020)

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
por: Shaw, Victoria E, et al.
Publicado: (2014)

A fine‐needle aspiration‐based protein signature discriminates benign from malignant breast lesions
por: Franzén, Bo, et al.
Publicado: (2018)

Evaluation of ADC(ratio) on liver MRI diffusion to discriminate benign versus malignant solid liver lesions
por: Pankaj Jain, Tarun, et al.
Publicado: (2018)

Diagnostic value of (18)F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs
por: Choi, Sunju, et al.
Publicado: (2022)

Evaluation of T1/T2 ratios in a pilot study as a potential biomarker of biopsy: proven benign and malignant breast lesions in correlation with histopathological disease stage
por: Malikova, Marina A, et al.
Publicado: (2017)

The Serum Glycome to Discriminate between Early-Stage Epithelial Ovarian Cancer and Benign Ovarian Diseases
por: Biskup, Karina, et al.
Publicado: (2014)

Fracture risk assessment in children with benign bone lesions of long bones
por: Li, Hai-Bing, et al.
Publicado: (2021)

Discrimination of Benign and Malignant Lesions in Canine Mammary Tissue Samples Using Raman Spectroscopy: A Pilot Study
por: Dantas, Diana, et al.
Publicado: (2020)

Artificial Intelligence-Based Multiclass Classification of Benign or Malignant Mucosal Lesions of the Stomach
por: Ma, Bowei, et al.
Publicado: (2020)

Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions
por: Zhang, Jieying, et al.
Publicado: (2022)

Radiomics for Discrimination between Early-Stage Nasopharyngeal Carcinoma and Benign Hyperplasia with Stable Feature Selection on MRI
por: Wong, Lun M., et al.
Publicado: (2022)

Quantitative discrimination between invasive ductal carcinomas and benign lesions based on semi-automatic analysis of time intensity curves from breast dynamic contrast enhanced MRI
por: Yin, Jiandong, et al.
Publicado: (2015)

Urine proteomics identifies biomarkers for diabetic kidney disease at different stages
por: Fan, Guanjie, et al.
Publicado: (2021)

Urine Metabolome Dynamics Discriminate Influenza Vaccination Response
por: Rodrick, Tori C., et al.
Publicado: (2023)

Discrimination of cancerous from benign pigmented skin lesions based on multispectral autofluorescence lifetime imaging dermoscopy and machine learning
por: Vasanthakumari, Priyanka, et al.
Publicado: (2022)

Discriminative deep learning based benignity/malignancy diagnosis of dermatologic ultrasound skin lesions with pretrained artificial intelligence architecture
por: Laverde‐Saad, Alexandra, et al.
Publicado: (2021)

Ultrasonography of benign vulvar lesions
por: Cheung, Vincent Y. T.
Publicado: (2018)

Potential urine biomarkers for gestational hypertension and preeclampsia
por: Guo, Hong-Xia, et al.
Publicado: (2019)

Computational Pathology to Discriminate Benign from Malignant Intraductal Proliferations of the Breast
por: Dong, Fei, et al.
Publicado: (2014)

Comprehensive biomarker profiles and chemometric filtering of urinary metabolomics for effective discrimination of prostate carcinoma from benign hyperplasia
por: Amante, Eleonora, et al.
Publicado: (2022)

Viscoelastic biomarker for differentiation of benign and malignant breast lesion in ultra- low frequency range
por: Nabavizadeh, Alireza, et al.
Publicado: (2019)

Urine miR-21-5p as a potential biomarker for predicting effectiveness of tadalafil in benign prostatic hyperplasia
por: Tanaka, Tomoaki, et al.
Publicado: (2018)

Intravoxel incoherent motion diffusion MR and diffusion kurtosis imaging for discriminating atypical bone metastasis from benign bone lesion
por: Wu, Gang, et al.
Publicado: (2019)

The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population
por: Loudini, Naila, et al.
Publicado: (2020)

Clinical features combined with ultrasound-based radiomics nomogram for discrimination between benign and malignant lesions in ultrasound suspected supraclavicular lymphadenectasis
por: Luo, Jieli, et al.
Publicado: (2023)

Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
por: Vago, Riccardo, et al.
Publicado: (2020)

Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021)

Elevated Levels of Oxidative Nucleic Acid Modification Markers in Urine From Gastric Cancer Patients: Quantitative Analysis by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry
por: Chen, Qin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gvvt4k84fcg6ldk9sjc9b9alia